Metastasectomy of Abdominal Wall Lesions due to Prostate Cancer Detected Through PET/CT Gallium 68-PMSA: First Case Report

Abstract

Introducing the topic of abdominal wall metastasis secondary to prostate cancer with a reminder of the disease's rarity, being the first published case. This article is about a 66 year old patient diagnosed with prostate cancer [cT2aNxMx iPSA: 5,6 ng/ml Gleason 3+3, (Grade 1 Group)], treated with radical prostatectomy as well as accompanied with amplified pelvic lymphadenectomy, who subsequently presented metastatic lesions to the abdominal wall diagnosed with PET/CT Gallium 68-PMSA technique and treated with abdominal metastasectomy with adequate short term results.

Solitary Abdominal Wall Lymph Node Recurrence in Prostate Cancer Patient with Dramatic Prostate-Specific Antigen Decrease following Metastasectomy

“…Those options can have a markedly variable success rates [4]. Metastasectomy has been reported in a few case reports to reduce PSA to undetectable levels, like our patient, suggesting a benefit for patient survival and cancer cure [5]. The surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence (STOMP) trial hopes to characterise the benefit of metastasis-directed therapy (MTD) by randomizing patients to receive either active surveillance or MTD followed by active surveillance in patients with oligometastases.…”

The current role of precision surgery in oligometastatic prostate cancer

“…A few case reports and a limited number of larger series reported on metastasectomy, but the overall evidence is scarce. 90 , 91 , 92 …”